1-11 of 11
Jo-Ann I. Sheppard
Close
Sort by
Journal Articles

High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Lori-Ann Linkins, Donald M. Arnold, Ishac Nazy
Journal: Blood
Blood (2018) 132 (12): 1345–1349.
https://doi.org/10.1182/blood-2018-04-847483
Published: 2018
Journal Articles

Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma

Hira Mian, Theodore E. Warkentin, Jo-Ann I. Sheppard, Anna MacDonald, Lori-Ann Linkins, Ann Benger, Ronan Foley
Journal: Blood
Blood (2017) 130 (14): 1679–1682.
https://doi.org/10.1182/blood-2017-06-788679
Published: 2017
Journal Articles

Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities

Brief Report
Theodore E. Warkentin, Jo-Ann I. Sheppard, F. Victor Chu, Anil Kapoor, Mark A. Crowther, Azim Gangji
Journal: Blood
Blood (2015) 125 (1): 195–198.
https://doi.org/10.1182/blood-2014-07-590844
Published: 2015
Journal Articles

Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard
Journal: Blood
Blood (2014) 123 (16): 2485–2493.
https://doi.org/10.1182/blood-2013-10-533083
Published: 2014
Journal Articles

Studies of the immune response in heparin-induced thrombocytopenia

Theodore E. Warkentin, Jo-Ann I. Sheppard, Jane C. Moore, Richard J. Cook, John G. Kelton
Journal: Blood
Blood (2009) 113 (20): 4963–4969.
https://doi.org/10.1182/blood-2008-10-186064
Published: 2009
Includes: Supplemental data
Journal Articles

The temporal profile of the anti-PF4/heparin immune response

Andreas Greinacher, Thomas Kohlmann, Ulrike Strobel, Jo-Ann I. Sheppard, Theodore E. Warkentin
Journal: Blood
Blood (2009) 113 (20): 4970–4976.
https://doi.org/10.1182/blood-2008-08-173062
Published: 2009
Journal Articles

Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Christopher S. Sigouin, Thomas Kohlmann, Petra Eichler, Andreas Greinacher
Journal: Blood
Blood (2006) 108 (9): 2937–2941.
https://doi.org/10.1182/blood-2005-11-012450
Published: 2006
Journal Articles

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Clinical Trials & Observations
Theodore E. Warkentin, Richard J. Cook, Victor J. Marder, Jo-Ann I. Sheppard, Jane C. Moore, Bengt I. Eriksson, Andreas Greinacher, John G. Kelton
Journal: Blood
Blood (2005) 106 (12): 3791–3796.
https://doi.org/10.1182/blood-2005-05-1938
Published: 2005
Journal Articles

Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.

Theodore E. Warkentin, MD, Jo-Ann I. Sheppard, Jane C. Moore, Kathleen M. Moore, Christopher S. Sigouin, John G. Kelton, MD
Journal: Blood
Blood (2004) 104 (11): 3022.
https://doi.org/10.1182/blood.V104.11.3022.3022
Published: 2004
Journal Articles

Argatroban Inhibits Human Factor Xa at Therapeutic Drug Levels: An Explanation for Its Prolongation of the INR.

Theodore E. Warkentin, MD, Andreas Greinacher, MD, Sharon Craven, Lori Dewar, Jo-Ann I. Sheppard, Frederick A. Ofosu, PhD
Journal: Blood
Blood (2004) 104 (11): 1845.
https://doi.org/10.1182/blood.V104.11.1845.1845
Published: 2004
Journal Articles

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Clinical Trials & Observations
Theodore E. Warkentin, Jo-Ann I. Sheppard, Peter Horsewood, Patricia J. Simpson, Jane C. Moore, John G. Kelton
Journal: Blood
Blood (2000) 96 (5): 1703–1708.
https://doi.org/10.1182/blood.V96.5.1703
Published: 2000